Filing Details
- Accession Number:
- 0000950170-24-113738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-09 16:05:05
- Reporting Period:
- 2024-10-07
- Accepted Time:
- 2024-10-09 16:05:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Revvity Inc. | RVTY | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408107 | S Tajinder Vohra | 77 4Th Avenue Waltham MA 02451-7567 | Please See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-10-07 | 2,053 | $122.04 | 24,060 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-07 | 100 | $123.05 | 23,960 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-08 | 1,661 | $122.47 | 22,299 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-08 | 493 | $122.99 | 21,806 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $121.68 to $122.56. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $121.88 to $122.86. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.90 to $123.06. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
